We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BASF licenses CRISPR-Cpf1 from the Broad Institute of MIT and Harvard

News   Oct 26, 2018 | Original Press Release from BASF

 
BASF licenses CRISPR-Cpf1 from the Broad Institute of MIT and Harvard

BASF technicians in a white biotechnology research lab in Germany are working with microorganisms to produce enzymes. Credit: BASF

 
 
Advertisement
 

RELATED ARTICLES

Reconstructing the Clock of Human Development

News

Researchers led by Kyoto University have reconstituted the human 'segmentation clock' -- a key focus of embryonic development research -- using induced pluripotent stem cells, iPSCs.

READ MORE

“Living Drug Factories” Could Help Treat Many Diseases

News

Chemical engineers have created a way to protect transplanted drug-producing cells from immune system rejection. The researchers hope that the technology could be used to treat many different diseases, including diabetes.

READ MORE

Advances in Production of Retinal Cells for Treating Blindness

News

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE